SGLT2 抑制剂对血管的影响:证据和机制
Beatriz R Góes-Santos1, Paulo C Castro2, Adriana C C Girardi2
1Faculdade de Educação Física, Universidade Estadual de Campinas (FEF-UNICAMP), Campinas, SP, Brazil.
American journal of physiology. Cell physiology
|September 4, 2025
概括
在糖尿病治疗之外,-葡萄糖携带体2抑制剂 (SGLT2i) 提供显著的心脏和脏保护. 这些药物改善血管功能,减少心力衰竭住院,减缓慢性病的进展.
科学领域:
- 心血管医学
- 肝脏病学
- 药理学
背景情况:
- 对2型糖尿病 (T2DM) 开发了-葡萄糖携带体2抑制剂 (SGLT2i).
- 临床证据表明,SGLT2i提供了超出血糖控制的益处,包括心力衰竭 (HF) 和慢性病 (CKD) 的保护.
- 这些影响扩展到患有心血管疾病的非糖尿病患者.
研究的目的:
- 审查SGLT2i对血管的多方面的益处.
- 总结目前对SGLT2i血管作用的临床和机制见解.
- 探索SGLT2i在恶性瘤和性别特异性的作用.
主要方法:
- 对SGLT2i的临床证据和机制研究的审查.
- 对SGLT2i对内皮细胞,血管光滑肌细胞和周围神经的影响的分析.
- 讨论血液动力学调节和直接细胞作用.
主要成果:
- SGLT2i对大血管和小血管功能表现出性作用.
- 机制包括减弱内皮细胞亡,铁亡和热亡.
- 改善细胞活力,增殖,血管生成,并增强eNOS活动.
- 对血管光滑肌细胞和神经的作用降低了度,改善了血管扩张.
结论:
- 通过血管作用介导的SGLT2i具有广泛的心脏和代谢益处.
- 了解这些机制对于优化治疗策略和患者选择至关重要.
- 需要进一步的研究,以充分利用SGLT2i的治疗潜力,包括性别特异性方面.
相关概念视频
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Secondary Active Transport
7.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.6K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
910
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
910
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
255
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
255
Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817


